Naftin Discussion Guide
naftin_discussion_guide
User Manual:
Open the PDF directly: View PDF 
.
Page Count: 2
| Download | |
| Open PDF In Browser | View PDF |
Doctor Discussion Guide: Starting the Conversation Answer the following questions to personalize your discussion guide. Space is provided at the end to make any additional notes you feel would be helpful. Share with your healthcare provider at your next visit. 1. I am concerned that I have: [Check all that apply.] ¨ Athlete’s foot between the toes ¨ Ringworm ¨ Jock itch 2. My symptoms are: ¨ Itching, burning, cracked skin between toes ¨ Red skin rash on body or arms and legs ¨ Itchy, burning rash in groin area 3. I have had this infection for: ¨ Less than a week ¨ More than a week ¨ More than a month ¨ I can’t remember when I didn’t have it 4. I would describe my discomfort as: ¨ Minimal ¨ Moderate ¨ Severe 5. My condition: ¨ Gets better but comes back ¨ Has not changed since the infection started 6. To treat my fungal infection: ¨ I have used topical solutions ¨ I have used natural remedies ¨ I have been treated with a prescription medicine ¨ I have made lifestyle changes ¨ I haven’t sought help until now 7. Please make a note of any questions you would like to discuss with your healthcare provider, such as: “Would I benefit from treatment with NAFTIN Gel, 2% or NAFTIN Cream, 2%?” FILL OUT THIS DOCTOR DISCUSSION GUIDE AND BE SURE TO TAKE IT TO YOUR NEXT VISIT. NAFTIN Gel, 2% NAFTIN Cream, 2% INDICATIONS AND USAGE: NAFTIN (naftifine hydrochloride) Gel, 2% is an allylamine antifungal indicated for the treatment of athlete’s foot between the toes caused by fungus in patients 12 years of age and older. INDICATIONS AND USAGE: NAFTIN (naftifine hydrochloride) Cream, 2% is indicated for the treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organism Trichophyton rubrum in patients 12 years of age and older. WARNING: If there is redness or irritation on the skin with the use of NAFTIN Gel, 2%, stop treatment and speak with your doctor. WARNING: If there is redness or irritation on the skin with the use of NAFTIN Cream, 2%, stop treatment and speak with your doctor. Information for Patients: Information for Patients: 1. NAFTIN Gel, 2% is only for use on top of the skin. NAFTIN Gel, 2% should not be used in the mouth, eyes, or vagina. 1. NAFTIN Cream, 2% is only for use on top of the skin. NAFTIN Cream, 2% should not be used in the mouth, eyes, or vagina. 2. If there is irritation or redness with the use of NAFTIN Gel, 2%, treatment should be stopped. Contact your doctor if you have irritation or redness on the skin after using NAFTIN Gel, 2%. 2. If there is irritation or redness with the use of NAFTIN Cream, 2%, treatment should be stopped. Contact your doctor if you have irritation or redness on the skin after using NAFTIN Cream, 2%. Cancer Risk: It is not known whether NAFTIN causes cancer or causes a risk of cancer. Long-term studies to evaluate the risk of cancer from NAFTIN Gel, 2% have not been done. Cancer Risk: It is not known whether NAFTIN causes cancer or causes a risk of cancer. Long-term studies to evaluate the risk of cancer from NAFTIN Cream, 2% have not been done. Pregnancy: Let your doctor know if you are pregnant or plan to become pregnant. NAFTIN Gel, 2% should be used during pregnancy only if the benefit to the mother is greater than the risk to the unborn baby. Pregnancy: Let your doctor know if you are pregnant or plan to become pregnant. NAFTIN Cream, 2% should be used during pregnancy only if the benefit to the mother is greater than the risk to the unborn baby. Nursing Mothers: It is not known whether this drug passes into breast milk. Because many drugs pass into breast milk, women who are nursing should take care when using NAFTIN Gel, 2%. Nursing Mothers: It is not known whether this drug passes into breast milk. Because many drugs pass into breast milk, women who are nursing should take care when using NAFTIN Cream, 2%. Pediatric Use: Safety and effectiveness in children under 12 years old has not been proven. Pediatric Use: Safety and effectiveness in children under 12 years old has not been proven. SIDE EFFECTS: In clinical trials with NAFTIN Gel 2%, the most common side effect was itching on the skin where the medicine was applied. SIDE EFFECTS: In clinical trials with NAFTIN Cream 2%, the most common side effect was itching on the skin where the medicine was applied. NAFTIN Gel, 2% is manufactured for Merz Pharmaceuticals, LLC, Raleigh, NC 27615. NAFTIN is a registered trademark of Merz Pharmaceuticals, LLC. The Merz logo is a registered trademark of Merz Pharma GmbH & Co. KGaA. © 2015 Merz North America, Inc. All rights reserved. XXXXXXX-XX
Source Exif Data:
File Type : PDF File Type Extension : pdf MIME Type : application/pdf PDF Version : 1.5 Linearized : Yes XMP Toolkit : Adobe XMP Core 5.6-c014 79.156797, 2014/08/20-09:53:02 Create Date : 2015:03:10 10:18:40-04:00 Metadata Date : 2015:03:10 10:18:41-04:00 Modify Date : 2015:03:10 10:18:41-04:00 Creator Tool : Adobe InDesign CC 2014 (Macintosh) Instance ID : uuid:9a37af84-c4f7-7a40-a15a-38f7ba966c5d Original Document ID : xmp.did:44f50892-7e65-494c-bba9-ea072b1cab59 Document ID : xmp.id:0d2e86e2-5432-419b-a3f4-2c231d072682 Rendition Class : proof:pdf Derived From Instance ID : xmp.iid:15415355-e2d0-41a3-a6bf-62f98db104f8 Derived From Document ID : xmp.did:e859d021-7cab-42a2-abbf-a3679cba897a Derived From Original Document ID: xmp.did:44f50892-7e65-494c-bba9-ea072b1cab59 Derived From Rendition Class : default History Action : converted History Parameters : from application/x-indesign to application/pdf History Software Agent : Adobe InDesign CC 2014 (Macintosh) History Changed : / History When : 2015:03:10 10:18:40-04:00 Format : application/pdf Producer : Adobe PDF Library 11.0 Trapped : False Page Count : 2 Creator : Adobe InDesign CC 2014 (Macintosh)EXIF Metadata provided by EXIF.tools